Switch to:
Sanofi (NYSE:SNY)
Cash from Financing
$-22,044 Mil (TTM As of Dec. 2014)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2014, Sanofi paid $1,381 Mil more to buy back shares than it received from issuing new shares. It spent $464 Mil paying down its debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $4,545 Mil paying cash dividends to shareholders. It received $2 Mil on other financial activities. In all, Sanofi spent $6,387 Mil on financial activities for the three months ended in Dec. 2014.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Sanofi's Cash from Financing for the fiscal year that ended in Dec. 2014 is calculated as:

Cash from Financing(A: Dec. 2014 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-1381.01109741+-463.625154131+0+-4545.00616523+2.46609124538
=-6,387

Sanofi's Cash from Financing for the quarter that ended in Dec. 2014 is

Cash from Financing(Q: Dec. 2014 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-1381.01109741+-463.625154131+0+-4545.00616523+2.46609124538
=-6,387

Sanofi Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2014 was -4650.39577836 (Jun. 2013 ) + -5111.11111111 (Dec. 2013 ) + -5895.38043478 (Jun. 2014 ) + -6387.17632552 (Dec. 2014 ) = $-22,044 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Sanofi's net issuance of stock for the three months ended in Dec. 2014 was $-1,381 Mil. Sanofi paid $1,381 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Sanofi's net issuance of debt for the three months ended in Dec. 2014 was $-464 Mil. Sanofi spent $464 Mil paying down its debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Sanofi's net issuance of preferred for the three months ended in Dec. 2014 was $0 Mil. Sanofi paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Sanofi's cash flow for dividends for the three months ended in Dec. 2014 was $-4,545 Mil. Sanofi spent $4,545 Mil paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Sanofi's other financing for the three months ended in Dec. 2014 was $2 Mil. Sanofi received $2 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Sanofi Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
Net Issuance of Stock 497471-2,201-1,581245-325-1,317-232-871-1,381
Net Issuance of Debt -5,678-5,497-1,361932,803-1,5426,951-807822-464
Net Issuance of Preferred 0000000000
Dividends -1,913-2,697-3,454-3,659-4,195-4,151-1,828-4,589-5,007-4,545
Other Financing -0-10-0-00-128-0-81-552
Cash from Financing -7,094-7,733-7,016-5,147-1,147-6,1473,807-5,710-5,111-6,387

Sanofi Quarterly Data

Jun10Dec10Jun11Dec11Jun12Dec12Jun13Dec13Jun14Dec14
Net Issuance of Stock -50-325-121-1,317-477-232-197-871-1,049-1,381
Net Issuance of Debt -290-1,54216,4356,951784-807359822156-464
Net Issuance of Preferred 0000000000
Dividends -3,828-4,151-1,993-1,828-4,386-4,589-4,811-5,007-5,003-4,545
Other Financing -382-128210-0-25-81-1-5502
Cash from Financing -4,549-6,14714,5323,807-4,104-5,710-4,650-5,111-5,895-6,387
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK